British Pharmacopoeia (BP) Website

This series contains dated gathered versions (or 'snapshots') of the British Pharmacopoeia website.

[Please note: These records may be accessed via the UK Government Web Archive using the links listed below (for a general explanation of these parallel links, please see the Arrangement field)]:

British Pharmacopoeia Commission (http://www.pharmacopoeia.co.uk).

British Pharmacopoeia (http://www.pharmacopoeia.gov.uk/)] .

British Pharmacopoeia Commission (http://pharmacopoeia.mhra.gov.uk/).

British Pharmacopoeia Commission (BPC) (pharmacopoeia.com) (https://www.pharmacopoeia.com/).

Please see information at Divisional level.

This series contains more than one link to the 'snapshots' of this website. For some websites, the URL may change periodically. Despite this change to the URL these websites are part of the same record series as they represent the department or organisation's presence on the web at the time. Occasionally, more than one domain URL to the same website may run in parallel creating an overlap.

UK Pharmacopoeial activity is carried out within the Inspection, Enforcement and Standards Division of MHRA by the British Pharmacopoeia Commission Secretariat and the British Pharmacopoeia Laboratory.

The first edition of the British Pharmacopoeia was published in 1864 and was one of the first attempts to harmonise pharmaceutical standards between different countries.

The British Pharmacopoeia Commission continues the work of the earlier Commissions appointed by the General Medical Council (GMC). A Commission was first appointed by the GMC when the body was made statutorily responsible under the Medical Act 1858 for producing a British Pharmacopoeia on a national basis. The 1968 Medicines Act established the legal status of the British Pharmacopoeia Commission and of the British Pharmacopoeia (BP) as the UK standard for medicinal products. The British Pharmacopoeia Commission is responsible for preparing new editions of the BP and the BP (Veterinary) and for keeping them up to date. Under Section 100 of the Medicines Act, the British Pharmacopoeia Commission is also responsible for selecting and devising British Approved Names (BANs).